The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of indicators emerge. While these technological innovations characterize exceptional progress in being familiar with neurodegenerative disorders, t... https://mickf297dnx7.eqnextwiki.com/user